Breakthrough Technology to Deliver Sustained Limus Release

Sustained Limus Release Drug-Eluting Balloon
For Coronary and Peripheral Indications

Breakthrough Technology

/

About Us

AB Medical is a newly established company headquartered in Athens, which engages in the import and distribution of advanced technological medical products in the healthcare market in Greece. Its focus of operation is in the Interventional Radiology and Interventional Cardiology fields where it offers the latest generation of drug-eluting balloon technology.

The company has managed to set the pace from the early beginnings of its operation as it counts its first strategic partnership with MedAlliance, a privately-owned medical technology company based in Nyon, Switzerland, with facilities in Irvine CA, Glasgow UK and Singapore. MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease. Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with SELUTION SLR™.

SELUTION SLR – Breakthrough Technology to Deliver Sustained Limus Release for up to 90 days1

SELUTION SLR is the latest generation of drug-eluting balloon technology for coronary and peripheral interventions with sustained limus release. Designed to deliver the same safety and performance as the best-in-class DES technology 2 with the added benefit of “leaving nothing behind”.

SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter

Intended for use as a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter to dilate de novo or restenotic coronary lesions, for the purpose of improving myocardial perfusion and decreasing the incidence of restenosis.

SELUTION SLR offers the broadest range of PTCA drug-eluting balloon catheters with balloon diameters ranging from 1.50 mm to 5.00 mm and lengths from 10 mm to 40 mm.

Read more

SELUTION SLR 018 Sirolimus Eluting PTA Balloon Catheter

Intended for use as a Percutaneous Transluminal Angioplasty (PTA) balloon catheter to dilate de novo or restenotic vascular lesions, for the purpose of improving limb perfusion and decreasing the incidence of restenosis.

SELUTION SLR offers the broadest range of PTA drug-eluting balloon catheters with balloon diameters ranging from 2.00 mm to 7.00 mm and lengths from 20 mm to 150 mm.

Read more
Data References:
1. Drug concentration evident in MicroReservoirs and tissue – Data on file at M.A. Med Alliance SA.
2. To achieve optimum performance from SELUTION SLR as a possible alternative to DES, follow the Instructions for Use in your implant procedure, and reference “How to use the drug-eluting balloon: recommendations by the German consensus group”, EuroIntervention 2011;7:K125-K128